NCT01020162View on ClinicalTrials.gov

Treatment of Ilioinguinal Entrapment Syndrome - an Often Overlooked Cause of Chronic Pelvic Pain

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 1995

Primary Completion Date

December 31, 2006

Study Completion Date

November 30, 2007

Conditions

Chronic Pelvic Pain

Interventions

DRUG

Amitryptiline, gabapentin

For amitryptiline starting dose 20-30 mg at night, increasing until clinical effect. For gabapentin was the initial dose 300 mg tid with rapid increases up to 800 mg tid.

PROCEDURE

Resection of the ilioinguinal nerve

In general anaesthesia the nerve was identified and resected as central as possible

Trial Locations (1)

S-41685

Dept Obstetrics&Gynecology/East Hospital, Gothenburg

All Listed Sponsors

lead

Göteborg University

OTHER

NCT01020162 - Treatment of Ilioinguinal Entrapment Syndrome - an Often Overlooked Cause of Chronic Pelvic Pain | Biotech Hunter | Biotech Hunter